C131H164F2N14O10 — CID 158419770
(2R)-2-[(3S,4S)-3-[[4-(benzimidazol-1-yl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-[difluoro(phenyl)methyl]-1H-pyrazol-5-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2S,3S,4S)-1-(cyclohexylmethyl)-3-phenyl-4-[[4-(3-phenyl-1,2-oxazol-5-yl)piperidin-1-yl]methyl]pyrrolidine-2-carboxylic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(5-phenyl-1,2-oxazol-3-yl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid (PubChem CID 158419770) has the molecular formula C131H164F2N14O10 and a molecular weight of 2132.84 g/mol. Its IUPAC name is (2R)-2-[(3S,4S)-3-[[4-(benzimidazol-1-yl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-[difluoro(phenyl)methyl]-1H-pyrazol-5-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2S,3S,4S)-1-(cyclohexylmethyl)-3-phenyl-4-[[4-(3-phenyl-1,2-oxazol-5-yl)piperidin-1-yl]methyl]pyrrolidine-2-carboxylic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(5-phenyl-1,2-oxazol-3-yl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid.
| Compound Name | (2R)-2-[(3S,4S)-3-[[4-(benzimidazol-1-yl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-[difluoro(phenyl)methyl]-1H-pyrazol-5-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2S,3S,4S)-1-(cyclohexylmethyl)-3-phenyl-4-[[4-(3-phenyl-1,2-oxazol-5-yl)piperidin-1-yl]methyl]pyrrolidine-2-carboxylic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(5-phenyl-1,2-oxazol-3-yl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid |
|---|---|
| PubChem CID | 158419770 |
| Molecular Formula | C131H164F2N14O10 |
| Molecular Weight | 2132.84 g/mol |
| Exact Mass | 2131.27 |
| IUPAC Name | (2R)-2-[(3S,4S)-3-[[4-(benzimidazol-1-yl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-[difluoro(phenyl)methyl]-1H-pyrazol-5-yl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2S,3S,4S)-1-(cyclohexylmethyl)-3-phenyl-4-[[4-(3-phenyl-1,2-oxazol-5-yl)piperidin-1-yl]methyl]pyrrolidine-2-carboxylic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-phenyl-4-[[4-(5-phenyl-1,2-oxazol-3-yl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid |
| SMILES | O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)on3)CC2)[C@@H](c2ccccc2)C1.O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(C(F)(F)c4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1.O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1.O=C(O)[C@@H]1[C@H](c2ccccc2)[C@@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)CN1CC1CCCCC1 |
| InChI | InChI=1S/C34H42F2N4O2.2C33H41N3O3.C31H40N4O2/c35-34(36,28-14-8-3-9-15-28)31-20-30(37-38-31)25-16-18-39(19-17-25)21-27-22-40(23-29(27)24-10-4-1-5-11-24)32(33(41)42)26-12-6-2-7-13-26;37-33(38)32(27-14-8-3-9-15-27)36-22-28(29(23-36)24-10-4-1-5-11-24)21-35-18-16-25(17-19-35)30-20-31(39-34-30)26-12-6-2-7-13-26;37-33(38)32-31(27-14-8-3-9-15-27)28(23-36(32)21-24-10-4-1-5-11-24)22-35-18-16-26(17-19-35)30-20-29(34-39-30)25-12-6-2-7-13-25;36-31(37)30(24-11-5-2-6-12-24)34-20-25(27(21-34)23-9-3-1-4-10-23)19-33-17-15-26(16-18-33)35-22-32-28-13-7-8-14-29(28)35/h1,3-5,8-11,14-15,20,25-27,29,32H,2,6-7,12-13,16-19,21-23H2,(H,37,38)(H,41,42);1-2,4-7,10-13,20,25,27-29,32H,3,8-9,14-19,21-23H2,(H,37,38);2-3,6-9,12-15,20,24,26,28,31-32H,1,4-5,10-11,16-19,21-23H2,(H,37,38);1,3-4,7-10,13-14,22,24-27,30H,2,5-6,11-12,15-21H2,(H,36,37)/t27-,29+,32+;28-,29+,32+;28-,31+,32-;25-,27+,30+/m0000/s1 |
| InChIKey | HAIRBSCWTFCPJO-GROZYLMXSA-N |
| XLogP | 24.44 |
| TPSA | 273.68 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 19 |
| Rotatable Bonds | 32 |
| Heavy Atoms | 157 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2132.84 |
| LogP ≤ 5 | 24.44 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 19 |